After centrifugation, the digested cells were resuspended, differentiated to adipocytes, and treated with 20 nmol/l exendin-4 for 24 h
visual field exams) [14, 27, 29, 34, 36,37,38,39]
For example, the tripeptide RGD, a common cell-targeting peptide, can serve as a targeting moiety for the anticancer drug cyclophosphamide (CP), offering high loading capacity and the potential for slow, prolonged drug release
This multifaceted action has made GLP-1 receptor agonistsmedications that mimic the effects of endogenous GLP-1valuable therapeutic agents for managing type 2 diabetes and, more recently, obesity
LEADER (liraglutide), SUSTAIN-6 (semaglutide), REWIND (dulaglutide) , (macroalbuminuria) [17,20,25]
Slow start Doses start very low and step up every 4 weeks